Public Company News
SwiftStart Confirms Strategic Investment Intent in TIRX, Beginning with $80 Million at $1.50 per Share
BEIJING, Jan. 28, 2026 /PRNewswire/ -- TIRX (Nasdaq: TIRX) (the "Company" or "TIRX") today announced that it has entered into a strategic Memorandum of Understanding ("MOU") with its strategic investor, SwiftStart Inc. Pursuant to the MOU, SwiftStart Inc. has expressed its intention to pursue an ...
2026-01-28 20:15
6349
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
* Ranked in the top one percent among more than 150,000 companies assessed globally * Recognized for strengthened sustainability management across all four assessment categories INCHEON, South Korea, Jan. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract developm...
2026-01-28 20:00
5468
New Oriental Announces Results for the Second Fiscal Quarter Ended November 30, 2025
BEIJING, Jan. 28, 2026 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced its unaudited financial results for the second fiscal quarter ended November 30, 2025...
2026-01-28 18:02
7298
SK hynix to establish U.S. arm specialized in AI solutions
- 'AI Company,' aims to become a key partner in the AI data center ecosystem - As the hub for SK Group's AI strategies, AI Co. will help accelerate AI advancement in global markets, including US and S. Korea. - "SK hynix will proactively seize opportunities in the upcoming AI era and deliver ex...
2026-01-28 17:18
6620
SK hynix Announces FY25 Financial Results… Posts Record-High Results and Delivers Highest Shareholder Returns
* Achieves all-time high annual and quarterly results, driven by AI memory competitiveness and high value-added products including HBM * Reports FY2025 revenue of 97.1467 trillion won, operating profit of 47.2063 trillion won, net profit of 42.9479 trillion won * Reports 4Q25 revenue of 32.8...
2026-01-28 16:42
8085
Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE:DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its fourth quarter and fiscal ...
2026-01-28 16:30
3439
NetEase to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the fourth quarter and fiscal year 2025 onWednesday, February 11, 2026, ...
2026-01-28 16:30
4085
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obes...
2026-01-28 12:08
4165
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center...
2026-01-27 22:00
7060
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....
2026-01-27 21:00
7995
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
* Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. * License and collaboration agreement strengthen Boehringer's inflammatory disease pipeline with a potential, first-in-class, pre-clinical asset. *...
2026-01-27 18:40
5572
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...
2026-01-27 08:00
5896
TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Delisting Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 26, 2026 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the "Company" or "TRX") today announced that it had received a written notification (the "Notice") from the Listing Qualifications (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 20, 2026, indicat...
2026-01-27 05:30
6935
Hesai Ranks No.1 in the World for Lidar Patents by KnowMade
PALO ALTO, Calif., Jan. 26, 2026 /PRNewswire/ -- In December 2025, KnowMade, a globally renowned intellectual property (IP) research firm under Yole Group, released itsLiDAR for Automotive Patent Landscape Analysis 2025, recognizing Hesai as a leader in the global lidar industry. In the report, H...
2026-01-26 22:00
5744
Jin Medical International Ltd. To Host Management Fireside Chat
CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment inChina, announced today that its Chief Executive Officer, tog...
2026-01-26 21:57
18202
Eastern International Ltd. Won the Bid for Its First Wind Power Construction Project Worth RMB 91.52 Million (Approx. USD 13.02 Million), Officially Marking Its Entry into the Wind Power Construction Sector
HANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Eastern International Ltd. ("Eastern International" or the "Company") (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services and construction services including project logistic, general logistic and new energy infras...
2026-01-26 21:30
5824
Lianhe Sowell International Group Ltd Announces Strategic Plan to Establish Specialized Industry Robotics Headquarters in the UAE
SHENZHEN, China, Jan. 26, 2026 /PRNewswire/ -- Lianhe Sowell International Group Ltd (Nasdaq: LHSW) (the "Company"), a provider of industrial machine vision products and solutions inChina, today announced its strategic plan to invest in and establish its first Specialized Industry Robotics Indust...
2026-01-26 21:30
11499
Daesang's K-Food Brand O'food Launches Kimchi Ramyun at Costco and Loblaws in Canada
- Two Kimchi Ramyun Varieties Now Available Across Canada
- Not just Kimchi flavor, Real Kimchi inside
SEOUL, South Korea, Jan. 26, 2026 /PRNewswire/ -- Daesang's leading Korean
food brand O'food has launched two Kimchi Ramyun products at Costco and Loblaws
inCanada.
2026-01-26 21:00
3744
Origin Agritech to Hold Business Update & Fiscal Year 2025 Earnings Conference Call on Monday, February 2 at 8 a.m. ET
BEIJING, Jan. 26, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, will announce its financial results for fiscal year 2025 onFriday, January 30. Origin will host a conference call onMonday, February 2, at 8 a...
2026-01-26 20:00
4420
Farmmi, Inc. Establishes New U.S. Subsidiary to Focus on Digital Marketing Business
LISHUI, China, Jan. 26, 2026 /PRNewswire/ -- Farmmi, Inc. (NASDAQ: FAMI) ("Farmmi" or the "Company"), today announced the establishment of a wholly-owned U.S. subsidiary, Bluesage Marketing Inc, which will conduct marketing business. This marks the Company's latest strategic development and the ...
2026-01-26 20:00
7664
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 327 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 308 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 305 media titles]
2026-02-26 19:57
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13
Most Read
/C O R R E C T I O N -- Republic Power Group Limited (NASDAQ: RPGL)/
2026-02-20 06:36
9225
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
2026-02-20 07:27
8501